Introduction:Ovarian cancer accounts for about 3% of all cancers in women and is one of the leading causes of mortality among all cancers of female genital tract. Incidence rate was 10.2/100,000 females in India in 2013. Study aimed to record the histopathological spectrum of ovarian neoplasms over a period of 1 year in a tertiary care hospital. Material and methods:This retrospective study was done for a period of 1 year (. Here we studied 70 cases of ovarian mass specimen received and fixed in 10%formalin. 4-5micrometer thick sections were cut on microtome and stained by H and E stain for Histopathological Examination Results: In this study, 70 cases of ovarian neoplasms were analysed. Out of these, 68 were primary and 02 were metastatic tumours. Amongst the primary ovarian tumours, 52 were benign, 5 were borderline and 11 were malignant. Histopathologically, surface epithelial tumours were the commonest (36), second most common was germ cell tumour (27) followed by sex cord stromal tumours (5). Benign tumours were common in 21-30 years of age, borderline tumours in 61-70 years of age and malignant tumours in 41-50 years age group. Conclusion:Ovary is a common site of neoplasia in the female genital tract and usually presents with a variety of clinicomorphological and histological features. We have observed an increased incidence of malignancy in our set up because patients usually present in advanced stages of disease, and this is an alarmig finding
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.